Ophthalmology News

The FDA accepted an investigational new drug application for a trispecific fusion antibody for the treatment of diabetic macular edema, according to a press release from Eluminex Biosciences.

One thousand physicians, health care providers and industry members will gather in Fort Lauderdale, Florida, in May for the Retina World Congress 2024 hosted in conjunction with Healio Live.

Ocular surface disease must be addressed before cataract surgery to ensure patient satisfaction and good surgical outcomes, according to a presentation at Real World Ophthalmology.

Subject dosing is complete in a phase 1/2 clinical trial of an allogeneic cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction, according to a press release.

In the rapidly evolving landscape of investments, it is crucial for physicians to stay informed about alternative asset classes, such as cryptocurrency.

AEYE Health has received the first-ever FDA clearance for a fully autonomous AI that can diagnose referable diabetic retinopathy using retinal images taken by a handheld camera, according to a company-issued press release.

Sight Sciences received a positive jury trial verdict of $34 million in a patent infringement case against Alcon and its Hydrus microstent, according to a press release.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, William F. Wiley, MD, ABO, discusses his positive experience using Iheezo, a preservative-free ocular anesthetic for anterior segment surgery.

The FDA has approved Lumify Preservative Free eye drops for the treatment of ocular redness due to minor eye irritations, according to a press release from manufacturer Bausch + Lomb.